تجاوز إلى المحتوى الرئيسي
User Image

Mohammad Shamsul Ola

Professor

Faculty

كلية العلوم
Research Group of Diabetic Retinopathy and Biochemical Toxicology and Nanobiochemistry; 2A 61, PO Box 2455, Building 5, Department of Biochemistry, College of Science, King Saud University, Riyadh
المنشورات
مقال فى مجلة
2024

Anti-Cholinergic Effects of the Phenolic Extract from the Astragalus crenatus Plant: A Computational and Network Pharmacology Study

Investigations into cholinesterase inhibition have received attention from researchers in recent years for the treatment of Alzheimer’s disease. Cholinesterase enzymes, namely, acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), hold pivotal significance in Alzheimer’s disease (AD) treatment. In this study, we utilized the ethanolic extract of Astragalus crenatus followed by liquid chromatography–electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS) to separate and identify at least 21 compounds in the extract. Rosmarinic acid exhibited the highest concentration (96.675 ± 1.3 mg/g extract), succeeded by hesperidin (79.613 ± 1.2 mg/g extract), hesperetin (75.102 ± 1.4 mg/g extract), rutin (68.156 ± 1.6 mg/g extract), chlorogenic acid (67.645 ± 1.5 mg/g extract), fisetin (66.647 ± 2.3 mg/g extract), and hyperoside (63.173 ± 1.5 mg/g extract). A. crenatus extract efficiently inhibited both AChE and BChE activities in a dosage-dependent manner. Molecular docking was employed to scrutinize the anticholinesterase mechanisms of the identified phytocompounds. Notably, a network pharmacology analysis was executed for the most efficacious compound. Based on binding energies, hesperidin emerged as the most potent inhibitor against both AChE and BChE, exhibiting scores of −10.5 Kcal/mol and −9.8 Kcal/mol, respectively. Due to its dual inhibition of AChE and BChE activities, hesperidin from Astragalus crenatus holds promise for the development of novel therapeutics aimed at neurological disorders, particularly AD.

اسم الناشر
MDPI
مدينة النشر
Switzerland
رقم المجلد
17
رقم الانشاء
3
مجلة/صحيفة
Pharmaceuticals
الصفحات
348
مزيد من المنشورات
publications

Glucose, the predominant carbohydrate in the human body, initiates nonenzymatic reactions in hyperglycemia, potentially leading to adverse biochemical interactions. This study investigates the…

بواسطة Additiya Paramanya, Abeeb Oyesiji Abiodun, Mohammad Shamsul Ola, Ahmad Ali
2024
تم النشر فى:
Wiley
publications

Investigations into cholinesterase inhibition have received attention from researchers in recent years for the treatment of Alzheimer’s disease. Cholinesterase enzymes, namely,…

بواسطة Sabrina Lekmine, Ouided Benslama, Hichem Tahraoui, Mohammad Shamsul Ola, Aicha Laouani, Kenza Kadi, Antonio Ignacio Martín-García, Ahmad Ali
2024
تم النشر فى:
MDPI
publications

Objective

بواسطة Archana Chaudhary, Nandani kumari, Manish kumar, Md. Margoob Ahmad, Mohammad Shamsul Ola & Rizwanul Haque
2024
تم النشر فى:
Springer